Atrial Fibrillation (AFib) Treatment: Medications, Procedures & Lifestyle
Atrial Fibrillation (AFib) is the most common sustained arrhythmia. Management follows **AHA/ACC/HRS guidelines**: stroke prevention + rate vs. rhythm control + lifestyle modification.
1. Stroke Prevention (CHA₂DS₂-VASc Score)
- Score ≥2 (men) / ≥3 (women) → **Oral Anticoagulation (OAC)** recommended.
- DOACs preferred: Apixaban, Rivaroxaban, Dabigatran, Edoxaban (over warfarin — no INR monitoring, lower intracranial bleed).
- Warfarin if: Mechanical mitral valve, moderate-severe mitral stenosis, ESRD on dialysis, cost/access barriers.
- Score 0 (men) / 1 (women) → No anticoagulation (or aspirin — no longer recommended).
2. Rate Control (First-Line for Most)
- Beta-Blockers: Metoprolol succinate, carvedilol, bisoprolol.
- Non-DHP Calcium Channel Blockers: Diltiazem, verapamil.
- Digoxin: Sedentary, HFpEF, or adjunct; not for rate control during exercise.
- Target: Resting HR <80 bpm (lenient <110 acceptable per RACE II).
3. Rhythm Control (Selected Patients)
- Symptomatic despite rate control, younger, first episode, HFref, athlete.
- Antiarrhythmics (AADs): Flecainide/propafenone (no structural HD), dofetilide/sotalol (HF), amiodarone (last resort — toxicity).
- Catheter Ablation: PVI (pulmonary vein isolation). Class I for symptomatic paroxysmal AFib refractory to ≥1 AAD. Increasingly first-line (CABANA, EAST-AFNET 4).
- Electrical Cardioversion: Synchronized shock for acute hemodynamic instability or planned (after 3 wks OAC or TEE-guided).
- Surgical Maze: Concomitant with cardiac surgery; standalone rare.
4. Lifestyle Modification (Class I Recommendation)
| Factor | Target |
|---|---|
| Weight | BMI <27; 10% loss → 6x AFib freedom |
| Alcohol | ≤1 drink/day (abstinence best) |
| Sleep Apnea | Screen & treat (CPAP) |
| Exercise | 150 min/week moderate (avoid extreme endurance) |
| Smoking | Cessation |
| Comorbidities | Optimize HTN, DM, lipids, thyroid |
